Accent Therapeutics: Bristol Myers, J&J fund Lexington cancer biotech's move into the clinic
A Lexington cancer biotech has attracted Series C funding from the likes of Bristol Myers Squibb, Johnson & Johnson's venture capital arm and a newly launched biotech VC firm.
Read full article »
Accent Therapeutics is a Massachusetts-based biopharmaceutical company that develops small-molecule precision therapies for the treatment of cancer.
Read more